Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
作者信息
Haymart Megan R, Miller David C, Hawley Sarah T
机构信息
From the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine (M.R.H.), the Institute for Healthcare Policy and Innovation (M.R.H., D.C.M., S.T.H.), the Department of Urology (D.C.M.), and the Division of General Medicine, Department of Internal Medicine (S.T.H.), University of Michigan, Ann Arbor.
出版信息
N Engl J Med. 2017 Jul 20;377(3):203-206. doi: 10.1056/NEJMp1703787.
Abstract
摘要
相似文献
1
Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
N Engl J Med. 2017 Jul 20;377(3):203-206. doi: 10.1056/NEJMp1703787.
2
Papillary thyroid microcarcinoma: optimal management versus overtreatment.
Curr Opin Oncol. 2020 Jan;32(1):1-6. doi: 10.1097/CCO.0000000000000595.
3
'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?
BJU Int. 2017 Apr;119(4):513-514. doi: 10.1111/bju.13734. Epub 2017 Jan 4.
4
Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
JAMA. 2018 Mar 20;319(11):1091-1092. doi: 10.1001/jama.2018.0018.
5
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Lancet Diabetes Endocrinol. 2016 Nov;4(11):933-942. doi: 10.1016/S2213-8587(16)30180-2. Epub 2016 Aug 20.
6
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
J Urol. 2013 Nov;190(5):1742-9. doi: 10.1016/j.juro.2013.05.054. Epub 2013 May 30.
7
[Active surveillance for low-risk prostate cancer].
Rev Prat. 2013 Apr;63(4):485-8.
8
Digital Imaging of the Breast: Is a Synthetic View Better?
J Natl Cancer Inst. 2016 Apr 2;108(4). doi: 10.1093/jnci/djw115. Print 2016 Apr.
9
Can advanced imaging reduce overdiagnosis and overtreatment?
Acad Radiol. 2015 Aug;22(8):1007-9. doi: 10.1016/j.acra.2015.06.001. Epub 2015 Jun 19.
10
[Active surveillance of prostatic cancer].
Duodecim. 2011;127(6):593-9.
引用本文的文献
1
Mediastinal Nodal Evaluation May Be Safely Omitted in Select Patients With Ground Glass-Dominant Lung Adenocarcinoma.
J Clin Oncol. 2025 Aug 14:JCO2501578. doi: 10.1200/JCO-25-01578.
2
Inconclusive cytology results of fine-needle aspiration for thyroid nodules: the importance of strict guideline implementation.
Ultrasonography. 2025 Jul;44(4):285-293. doi: 10.14366/usg.24216. Epub 2025 May 13.
3
Prediction model for lymph node metastasis in the right lateral region of papillary thyroid carcinoma.
Endocrine. 2025 Feb 10. doi: 10.1007/s12020-025-04188-w.
4
Impact of a simple informative leaflet on Brazilian doctors' attitudes towards active surveillance of thyroid microcarcinomas.
Heliyon. 2024 Sep 2;10(17):e37300. doi: 10.1016/j.heliyon.2024.e37300. eCollection 2024 Sep 15.
5
Evolution in the management of thyroid surgery over a period of 15 years in a Belgian center.
BMC Surg. 2024 Jun 15;24(1):188. doi: 10.1186/s12893-024-02471-7.
6
Impact of age on central lymph nodes involvement in papillary thyroid cancer.
BMC Cancer. 2024 Apr 5;24(1):423. doi: 10.1186/s12885-024-12198-6.
7
ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA).
BMC Cancer. 2023 Aug 9;23(1):737. doi: 10.1186/s12885-023-11237-y.
8
Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials.
Cancers (Basel). 2023 Jan 23;15(3):701. doi: 10.3390/cancers15030701.
9
Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions.
Abdom Radiol (NY). 2023 Mar;48(3):1079-1089. doi: 10.1007/s00261-022-03775-z. Epub 2022 Dec 17.
10
Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer.
JAMA Netw Open. 2022 Nov 1;5(11):e2242210. doi: 10.1001/jamanetworkopen.2022.42210.
本文引用的文献
1
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
2
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412.
3
CLINICAL DECISIONS. Ductal Carcinoma In Situ.
N Engl J Med. 2016 Jan 28;374(4):390-2. doi: 10.1056/NEJMclde1512213.
4
Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
J Natl Cancer Inst. 2015 Dec 17;108(5). doi: 10.1093/jnci/djv372. Print 2016 May.
5
Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.
N Engl J Med. 1993 Apr 29;328(17):1237-43. doi: 10.1056/NEJM199304293281706.
Zotero 插件